X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-11 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $7.32 | -4,727 | 125,120 | -4% | -$34,602 | ||||||
2024-08-07 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $7.42 | -5,022 | 129,847 | -4% | -$37,263 | ||||||
2024-05-08 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.59 | -4,902 | 134,869 | -4% | -$47,010 | ||||||
| DM | 2024-03-27 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $9.44 | -77,136 | 139,771 | -36% | -$727,853 | |||||
2024-03-26 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.55 | -21,438 | 143,524 | -13% | -$204,733 | ||||||
2024-03-25 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.10 | -22,163 | 164,962 | -12% | -$201,683 | ||||||
2024-03-06 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.02 | -1,664 | 187,125 | -1% | -$15,009 | ||||||
2024-02-06 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $8.03 | -5,665 | 188,789 | -3% | -$45,490 | ||||||
2023-12-07 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $4.80 | -5,000 | 194,454 | -3% | -$24,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |